What does the evidence say about Lactoferrin Supplementation Iron Status Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Lactoferrin Supplementation Iron Status Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - We link mechanistic insights with clinical and preclinical evidence and uniquely map molecular functions to dermatologic and trichologic outcomes. [Kaplan N (2026); evidence level 4] - Lactoferrin is a naturally occurring bioactive glycoprotein that is part of the body's innate immune system and has essential roles in iron metabolism, microbial defense, inflammation regulation, and tissue repair. [Kaplan N (2026); evidence level 4] - It supports the natural regulation of iron bioavailability in skin and hair follicles, helping to reduce excess free-iron-driven oxidative stress while preserving levels of necessary iron for cellular functions. [Kaplan N (2026); evidence level 4] - Women with IDWA may still experience fatigue, reduced concentration, impaired physical performance, and lower quality of life, and IDWA is estimated to affect approximately 15%-35% of women [,]. [Muacevic Alexander (2026); evidence level 4] - 13 14 15 15 Iron supplementation remains the standard treatment for iron deficiency; however, it is associated with many side effects, including gastrointestinal symptoms such as constipation, nausea, and abdominal discomfort [,]. [Muacevic Alexander (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.